Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
Aschauer L, Limonciel A, Wilmes A et al (2015) Application of RPTEC/TERT1 cells for investigation of repeat dose nephrotoxicity: a transcriptomic study
Schedule a consultation with our expert team today to discuss if NAD+ therapies are right for you.
and is not FDA-approved for any human application
US$ 28.99
US$ 22.45
US$ 29.39
US$ 27.33
US$ 29.96
US$ 27.24
